134 related articles for article (PubMed ID: 32896383)
1. The Effect of Tacrolimus Trough Variability on Kidney Transplant Outcomes.
Heeney S; Szempruch KR; Lee RM; Mintz A; Serrano P; Detwiler R; Doligalski C
Transplant Proc; 2020 Dec; 52(10):3129-3133. PubMed ID: 32896383
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
Solomon S; Colovai A; Del Rio M; Hayde N
Pediatr Nephrol; 2020 Feb; 35(2):261-270. PubMed ID: 31732803
[TBL] [Abstract][Full Text] [Related]
3. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development.
Rodrigo E; Segundo DS; Fernández-Fresnedo G; López-Hoyos M; Benito A; Ruiz JC; de Cos MA; Arias M
Transplantation; 2016 Nov; 100(11):2479-2485. PubMed ID: 26703349
[TBL] [Abstract][Full Text] [Related]
4. Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study.
Hiramitsu T; Tomosugi T; Futamura K; Okada M; Nishihira M; Goto N; Ichimori T; Narumi S; Kobayashi T; Uchida K; Watarai Y
Int Immunopharmacol; 2021 Feb; 91():107038. PubMed ID: 33388731
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
Jung HY; Seo MY; Jeon Y; Huh KH; Park JB; Jung CW; Lee S; Han SY; Ro H; Yang J; Ahn C; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
PLoS One; 2020; 15(7):e0235418. PubMed ID: 32614859
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies.
Davis S; Gralla J; Klem P; Stites E; Wiseman A; Cooper JE
Transplantation; 2020 Apr; 104(4):881-887. PubMed ID: 32224815
[TBL] [Abstract][Full Text] [Related]
7. Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantation.
Fujiyama N; Satoh S; Saito M; Numakura K; Inoue T; Yamamoto R; Saito T; Nara T; Kanda S; Narita S; Kagaya H; Miura M; Habuchi T
Int Immunopharmacol; 2019 Nov; 76():105881. PubMed ID: 31520989
[TBL] [Abstract][Full Text] [Related]
8. Intervention of Online Percent Coefficient of Variation Reporting System Reduces the Variability of Tacrolimus Trough Concentration in Kidney Transplant Recipients.
Cheng CY; Wu MJ; Lin CC; Hou YC; Liou WS
Transplant Proc; 2018 Oct; 50(8):2401-2403. PubMed ID: 30316366
[TBL] [Abstract][Full Text] [Related]
9. Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk.
Baghai Arassi M; Gauche L; Schmidt J; Höcker B; Rieger S; Süsal C; Tönshoff B; Fichtner A
Pediatr Nephrol; 2022 Oct; 37(10):2503-2514. PubMed ID: 35166920
[TBL] [Abstract][Full Text] [Related]
10. High tacrolimus intra-patient variability is associated with graft rejection, and
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
[TBL] [Abstract][Full Text] [Related]
11. Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus.
Taber DJ; Bartlett F; Patel N; Sprague T; Patel S; Newman J; Andrade E; Rao N; Salas MAP; Casey M; Dubay D; Rohan V
Clin Transplant; 2023 May; 37(5):e14941. PubMed ID: 36809653
[TBL] [Abstract][Full Text] [Related]
12. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
Wiebe C; Rush DN; Nevins TE; Birk PE; Blydt-Hansen T; Gibson IW; Goldberg A; Ho J; Karpinski M; Pochinco D; Sharma A; Storsley L; Matas AJ; Nickerson PW
J Am Soc Nephrol; 2017 Nov; 28(11):3353-3362. PubMed ID: 28729289
[TBL] [Abstract][Full Text] [Related]
13. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.
O'Regan JA; Canney M; Connaughton DM; O'Kelly P; Williams Y; Collier G; deFreitas DG; O'Seaghdha CM; Conlon PJ
J Nephrol; 2016 Apr; 29(2):269-276. PubMed ID: 26374111
[TBL] [Abstract][Full Text] [Related]
15. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
Sampaio MS; Chopra B; Sureshkumar KK
Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus trough levels in kidney transplant recipients.
Hwang YH; Kim H; Min K; Yang J
BMC Nephrol; 2021 Dec; 22(1):405. PubMed ID: 34876046
[TBL] [Abstract][Full Text] [Related]
17. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.
Abu Bakar K; Mohamad NA; Hodi Z; McCulloch T; Williams A; Christian M; Key T; Kim JJ
Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127
[TBL] [Abstract][Full Text] [Related]
18. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Doares W; Kaczmorski S; Farney AC
Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622
[TBL] [Abstract][Full Text] [Related]
19. Once- vs Twice-Daily Tacrolimus: Survival Rates and Side Effects: Single-Center Experience.
Turunc V; Ari E; Guven B; Tabendeh B; Yildiz A
Transplant Proc; 2019 Sep; 51(7):2308-2311. PubMed ID: 31400977
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.
Taber DJ; Su Z; Fleming JN; McGillicuddy JW; Posadas-Salas MA; Treiber FA; Dubay D; Srinivas TR; Mauldin PD; Moran WP; Baliga PK
Transplantation; 2017 Dec; 101(12):2931-2938. PubMed ID: 28658199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
